A
Aileron Therapeutics (ALRN)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aileron Therapeutics (ALRN)
Aileron Therapeutics, Inc. is a clinical-stage chemoprotection oncology company. It is focused on developing medicines to make chemotherapy safer. Its ALRN-6924 product is a MDM2/MDMX dual inhibitor that leverages its peptide drug technology, which i... Read more
- USD3.44
- USD3.45
- USD3.40
- USD7.42
- 22.90%
- --
- 6.74k
- 110.96k
- 77M
- 1.01
- 140.60%
Stock News
27 minutes ago
Why Brat Summer and Chappell Roan are boosting Hydro Flask parent company’s stock
MarketWatch
37 minutes ago
Here's what teenagers think about the iPhone 16 and new personal computers
CNBC
39 minutes ago
Rio Tinto’s $6.7 billion lithium deal could usher consolidation in key industry for EVs
MarketWatch
52 minutes ago
Google could face crippling blows to AI if U.S. government gets its way in antitrust case
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
